Pfizer plots Saudi Arabian manufacturing plant

Pfizer ($PFE) has inked a deal to build a new manufacturing plant in Saudi Arabia that will produce and package drugs beginning in 2015 with the help of as many as 200 workers. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.